Prof. Dr. Jun-ichi Tanuma | Oral Pathology | Best Researcher Award

Niigata University Graduate School of Medical and Dental Sciences | Japan

Prof. Dr. Jun-ichi Tanuma is a renowned scholar in oral pathology and oncology, recognized for his distinguished academic and clinical contributions. He earned his D.D.S. cum laude in 1994 and Ph.D. in 1998 from Kagoshima University, Japan. After passing the National Board Dentistry Examination, he trained as a pathology resident at Saitama Cancer Center and later served as Assistant and Associate Professor at Kagoshima University’s Graduate School of Medical and Dental Sciences, where he also completed a postdoctoral fellowship at the National Cancer Institute in Milan, Italy. He subsequently held prominent positions as Chief Professor at Asahi University and currently serves as Chief Professor and Chair of the Division of Oral Pathology at Niigata University. His professional certifications include a Japanese Dental License, Pathological Anatomy Diploma, and recognition as a Medical Specialist in Oral Pathology. With 72 publications, 844 citations, and an h-index of 15, he has made significant research contributions. His editorial, council, and reviewer roles across major scientific journals and societies further underscore his leadership and influence in global cancer pathology research.

Profile: Scopus | Orcid

Featured Publications

Tanuma, J., et al. (2024). Erratum: Correction: The effects of carbon-ion beam irradiation on three-dimensional in vitro models of normal oral mucosa and oral cancer: Development of a novel tool to evaluate cancer therapy. In Vitro Cellular & Developmental Biology – Animal, 60(10).

Tanuma, J., et al. (2024). Ladinin-1 in actin arcs of oral squamous cell carcinoma is involved in cell migration and epithelial phenotype. Scientific Reports, 14, Article 12345.

Tanuma, J., et al. (2024). The effects of carbon-ion beam irradiation on three-dimensional in vitro models of normal oral mucosa and oral cancer: Development of a novel tool to evaluate cancer therapy. In Vitro Cellular & Developmental Biology – Animal, 60(10).

Tanuma, J., et al. (2024). PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma. Scientific Reports, 14, Article 6789.

Tanuma, J., et al. (2024). Development and characterization of a three-dimensional organotypic in vitro oral cancer model with four co-cultured cell types, including patient-derived cancer-associated fibroblasts. Biomedicines, 12(4), Article 567.